HAROLD E SELICK
CIK 1287233 · Chief Executive Officer · last filed 2026-03-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.91M
Companies
6
Total Filings
64
Lifetime Open-Market Net
-$2.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTGX | Director | 60,845 | $146.49 | $8.91M | -$2.44M | 18 | 2026-03-27 |
| Molecular Templates, Inc. (MTEM) Delisted | Director | — | $0.00 | — | $0 | 8 | 2024-09-30 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Director | 256,828 | — | — | $48.5K | 11 | 2019-06-24 |
| CBIO | Director | — | $17.93 | — | $0 | 5 | 2018-01-18 |
| Molecular Templates, Inc. (THLD) Delisted | Chief Executive Officer | 41,217 | — | — | $229.8K | 18 | 2016-03-15 |
| Molecular Templates, Inc. (THLDD) Delisted | Chief Executive Officer | 239,480 | — | — | $0 | 2 | 2008-09-05 |
Recent Filings · Page 4 of 7
64 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-26 | PTGX | Grant (A) | — | $0 | EDGAR |
| 2016-09-15 | PTGX | Grant (A) | — | $0 | EDGAR |
| 2016-06-13 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2016-06-03 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +71,023 | $250.0K | EDGAR |
| 2016-03-15 | Molecular Templates, Inc. (THLD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-15 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2015-10-26 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2015-08-20 | — | Other (J) | +16,614 | $0 | |
| 2015-05-29 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +22,059 | $150.0K | EDGAR |
| 2015-03-02 | Molecular Templates, Inc. (THLD) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.